Qualcomm and Arm are back in court, and your next phone is on the line
AI-summarised brief · reviewed before publication
Qualcomm and Arm have resumed litigation in Delaware, launching a five‑day jury trial that could reshape smartphone chip licensing. Qualcomm seeks to suspend royalty payments for up to five years, citing Arm’s refusal to provide Nuvia testing tools and a leaked threat to terminate a key license. The dispute centers on Qualcomm’s 2021 Nuvia acquisition and a $170 million reduction in a Meta chip deal. Arm argues the changes stem from Meta’s pivot to AI glasses, not Qualcomm’s actions. The trial may alter future CPU technology negotiations and royalty structures.
💡 Why It Matters
- · The outcome could redefine how major chipmakers negotiate licensing terms, potentially shifting control over next‑generation processor designs.